Barchart.com
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Pmgc Holdings Inc (ELAB)

Pmgc Holdings Inc (ELAB)
4.69 -0.16 (-3.30%) 09:38 ET [NASDAQ]
4.54 x 1 4.84 x 2
Realtime by (Cboe BZX)
4.54 x 1 4.84 x 2
Realtime 4.71 -0.14 (-2.89%) 07:27 ET
News & Headlines for Fri, Mar 28th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K GlobeNewswire - Fri Mar 28, 7:00AM CDT

ELAB : 4.69 (-3.30%)
NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market GlobeNewswire - Thu Mar 27, 7:00AM CDT

ELAB : 4.69 (-3.30%)
PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules GlobeNewswire - Fri Mar 21, 1:41PM CDT

ELAB : 4.69 (-3.30%)
PMGC Holdings Announces Share Repurchases from Existing Shareholders GlobeNewswire - Fri Mar 21, 7:00AM CDT

ELAB : 4.69 (-3.30%)
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 GlobeNewswire - Mon Mar 10, 7:00AM CDT

ELAB : 4.69 (-3.30%)
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance GlobeNewswire - Thu Mar 6, 8:00AM CST

ELAB : 4.69 (-3.30%)
PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group GlobeNewswire - Thu Feb 27, 7:00AM CST

ELAB : 4.69 (-3.30%)
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market GlobeNewswire - Wed Feb 26, 7:30AM CST

ELAB : 4.69 (-3.30%)
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with... GlobeNewswire - Tue Feb 18, 6:00AM CST

ELAB : 4.69 (-3.30%)
Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1 GlobeNewswire - Tue Feb 4, 7:00AM CST

ELAB : 4.69 (-3.30%)

Barchart Exclusives

Has Primo Waters Sprung a Leak? Barchart - 1 hour ago
Summary Primo Brands Corporation (PRMB) shows strong technical indicators, including 88% technical buy signals, a 93.85% gain in the last year, and a Trend Seeker buy signal. The company operates a diverse portfolio of branded beverages and offers multiple water solutions, with a market cap of $13.42 billion and a... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies
Wed, Apr 02, 2025 5:00 PM UTC
Reserve Your Spot